Ongoing research is needed to assess potential risks associated with prolonged use, including cardiovascular effects and the development of pancreatitis or pancreatic cancer
Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jdar E, Kandler K, Rigas G, Wadden TA
Part A: incretins: concept and physiological functions
Other potential mechanisms : Various theoretical mechanisms have been proposed in scientific literature, though these remain speculative and lack robust evidence in humans
This trial made big news when it came out as it was one of the first trials to show that the benefits that GLP-1 receptor agonists confer to patients with diabetes also extend to those with overweight or obesity without diabetes, Dr